Eneli Oitmaa, the CEO of Asper Biotech gives an interview to the CE biotech.com about the current situation in genetic testing services in Asper Biotech and also company’s future perspectives in biotechnology market. Read the interview: http://cebiotech.com/articles/Asper-biotech-and-estonian-biotechnology-sector,300
Updated Noonan Syndrome Panel
Published 20/01/2015We have added six new genes (CBL, HRAS, KAT6B, MAP2K2, SHOC2, SPRED1) to the Noonan syndrome NGS panel. Now the panel includes 13 genes associated with Noonan syndrome and Noonan spectrum disorders.